Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Friday, November 15, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Why Green Packaging Matters: A Guide to Sustainable Choices
C.H. Robinson Launches Next-Gen Logistics Solutions
Telix and Eckert & Ziegler to Collaborate on Actinium-225 Production
Kratos Wins $116.7M Contract for Fire Control Ground System
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Amyloid Polyneuropathy
Amyloid Polyneuropathy
Biotechnology
Ionis Announces Eplontersen Met Co-primary and Secondary Endpoints in Interim Analysis of the Phase 3 NEURO-TTRansform Study
PR Newswire
-
June 21, 2022
Ionis Pharmaceuticals, Inc. announced positive topline results from a 35-week interim analysis of the Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca's eplontersen in...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Why Green Packaging Matters: A Guide to Sustainable Choices
C.H. Robinson Launches Next-Gen Logistics Solutions
Telix and Eckert & Ziegler to Collaborate on Actinium-225 Production
Load more
